John D. Newell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John D. Newell has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro A. Diaz
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
1 shared publication - Chandrika Christie
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Mo
1 shared publication D.A Lynch
National Jewish Medical and Research Center, 1400 Jackson Street, Room A011, Denver, Colorado, U.S.A.
1 shared publication- David S. Gierada
Department of Radiology, Washington University School of Medicine, St. Louis, MO
1 shared publication - E. Xueping
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Mo
1 shared publication - Edwin K. Silverman
Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
1 shared publication
Latest Publications
- 25 November 2009
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 6 (6) , 468-477
Quantitative Airway Assessment on Computed Tomography in Patients with α1-antitrypsin Deficiency
The relationship between quantitative airway measurements on computed tomography (CT) and airflow limitation in individuals with severe α 1-antitrypsin deficiency (AATD) is undefined. Thus, we planned to clarify the relationship between CT-based airway indices and airflow limitation in AATD. 52 patients with AATD underwent chest CT and pre-bronchodilator spirometry at three institutions. In the right upper (RUL) and lower (RLL) lobes, wall area percent (WA%) and luminal area (Ai) were measured in the third, fourth, and fifth generations of the bronchi. The severity of emphysema was also calculated in each lobe and expressed as low attenuation area percent (LAA%). Correlations between obtained measurements and FEV1% predicted (FEV1%P) were evaluated by the Spearman rank correlation test. In RUL, WA% of all generations was significantly correlated with FEV1%P (3rd, R = −0.33, p = 0.02; 4th, R = −0.39, p = 0.004; 5th, R = −0.57, p < 0.001; respectively). Ai also showed significant correlations (3rd, R = 0.32, p = 0.02; 4th, R = 0.34, p = 0.01; 5th, R = 0.56, p < 0.001; respectively). Measured correlation coefficients improved when the airway progressed distally from the third to fifth generations. LAA% also correlated with FEV1%P (R = −0.51, p < 0.001). In RLL, WA% showed weak correlations with FEV1%P in all generations (3rd, R = −0.34, p = 0.01; 4th, R = −0.30, p = 0.03; 5th, R = −0.31, p = 0.03; respectively). Only Ai from the fifth generation significantly correlated with FEV1%P in this lobe (R = 0.34, p = 0.01). LAA% strongly correlated with FEV1%P (R = −0.71, p < 0.001). We conclude therefore that quantitative airway measurements are significantly correlated with airflow limitation in AATD, particularly in the distal airways of RUL. Emphysema of the lower lung is the predominant component; however, airway disease also has a significant impact on airflow limitation in AATD.
- 25 November 2009
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 6 (6) , 468-477
Quantitative Airway Assessment on Computed Tomography in Patients with α1-antitrypsin Deficiency
The relationship between quantitative airway measurements on computed tomography (CT) and airflow limitation in individuals with severe α 1-antitrypsin deficiency (AATD) is undefined. Thus, we planned to clarify the relationship between CT-based airway indices and airflow limitation in AATD. 52 patients with AATD underwent chest CT and pre-bronchodilator spirometry at three institutions. In the right upper (RUL) and lower (RLL) lobes, wall area percent (WA%) and luminal area (Ai) were measured in the third, fourth, and fifth generations of the bronchi. The severity of emphysema was also calculated in each lobe and expressed as low attenuation area percent (LAA%). Correlations between obtained measurements and FEV1% predicted (FEV1%P) were evaluated by the Spearman rank correlation test. In RUL, WA% of all generations was significantly correlated with FEV1%P (3rd, R = −0.33, p = 0.02; 4th, R = −0.39, p = 0.004; 5th, R = −0.57, p < 0.001; respectively). Ai also showed significant correlations (3rd, R = 0.32, p = 0.02; 4th, R = 0.34, p = 0.01; 5th, R = 0.56, p < 0.001; respectively). Measured correlation coefficients improved when the airway progressed distally from the third to fifth generations. LAA% also correlated with FEV1%P (R = −0.51, p < 0.001). In RLL, WA% showed weak correlations with FEV1%P in all generations (3rd, R = −0.34, p = 0.01; 4th, R = −0.30, p = 0.03; 5th, R = −0.31, p = 0.03; respectively). Only Ai from the fifth generation significantly correlated with FEV1%P in this lobe (R = 0.34, p = 0.01). LAA% strongly correlated with FEV1%P (R = −0.71, p < 0.001). We conclude therefore that quantitative airway measurements are significantly correlated with airflow limitation in AATD, particularly in the distal airways of RUL. Emphysema of the lower lung is the predominant component; however, airway disease also has a significant impact on airflow limitation in AATD.
- 15 December 2008
- Published by Oxford University Press (OUP) in Proceedings of the American Thoracic Society
- Vol. 5 (9) , 915-918
Quantitative Computed Tomography of Lung Parenchyma in Chronic Obstructive Pulmonary Disease: An Overview
This article provides a brief overview of the important issues influencing the effective use of quantitative X-ray computed tomography (QCT) in the assessment of the lung parenchyma in patients or research subjects with chronic obstructive pulmonary disease (COPD). This effort builds on an earlier workshop that was done in 2001. The pathologic appearance of emphysema is briefly reviewed. CT scanner, CT phantom, and CT image acquisition parameters are discussed that are important in obtaining high quality CT images of the lungs for image quantitation. Data storage, data transfer and data archival issues are reviewed. Current image processing techniques to derive meaningful quantitative measures of emphysema are also discussed.
- 15 December 2008
- Published by Oxford University Press (OUP) in Proceedings of the American Thoracic Society
- Vol. 5 (9) , 915-918
Quantitative Computed Tomography of Lung Parenchyma in Chronic Obstructive Pulmonary Disease: An Overview
This article provides a brief overview of the important issues influencing the effective use of quantitative X-ray computed tomography (QCT) in the assessment of the lung parenchyma in patients or research subjects with chronic obstructive pulmonary disease (COPD). This effort builds on an earlier workshop that was done in 2001. The pathologic appearance of emphysema is briefly reviewed. CT scanner, CT phantom, and CT image acquisition parameters are discussed that are important in obtaining high quality CT images of the lungs for image quantitation. Data storage, data transfer and data archival issues are reviewed. Current image processing techniques to derive meaningful quantitative measures of emphysema are also discussed.
- 1 May 2004
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 23 (5) , 769-775
Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema
It has been reported that quantitative computed tomography (CT) scanning of the lungs showed decreased progression of emphysema in a randomised clinical trial in patients with severe α1‐antitrypsin (α1‐AT) deficiency receiving monthly intravenous augmentation therapy with human α1‐AT. Comparable results were not obtained using rate of decline of forced expiratory volume in one second.Accordingly, the Alpha‐1 Foundation convened a workshop to explore the feasibility of using quantitative CT data as a primary outcome variable in trials of drugs for treating α1‐AT deficiency.This report reviews the following: the principles for the use of modern CT scanners for quantifying emphysema; the methods and data on validation by comparison with measurements of severity of emphysema in inflation-fixed specimens of lungs; and the possibility of decreasing radiation dosage from CT to make it safe and ethically possible to use CT in longitudinal studies.The workshop concluded that it is feasible, safe and ethically possible to use computed tomography in longitudinal studies of emphysema. It recommended that the primary end-point should be a significant shift in the 15th percentile of lung density.
- 1 May 2004
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 23 (5) , 769-775
Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema
It has been reported that quantitative computed tomography (CT) scanning of the lungs showed decreased progression of emphysema in a randomised clinical trial in patients with severe α1‐antitrypsin (α1‐AT) deficiency receiving monthly intravenous augmentation therapy with human α1‐AT. Comparable results were not obtained using rate of decline of forced expiratory volume in one second.Accordingly, the Alpha‐1 Foundation convened a workshop to explore the feasibility of using quantitative CT data as a primary outcome variable in trials of drugs for treating α1‐AT deficiency.This report reviews the following: the principles for the use of modern CT scanners for quantifying emphysema; the methods and data on validation by comparison with measurements of severity of emphysema in inflation-fixed specimens of lungs; and the possibility of decreasing radiation dosage from CT to make it safe and ethically possible to use CT in longitudinal studies.The workshop concluded that it is feasible, safe and ethically possible to use computed tomography in longitudinal studies of emphysema. It recommended that the primary end-point should be a significant shift in the 15th percentile of lung density.
- 1 December 2002
- Published by Elsevier in Clinical Radiology
- Vol. 57 (12) , 1078-1085
High-resolution CT Features of Severe Asthma and Bronchiolitis Obliterans
- 1 December 2002
- Published by Elsevier in Clinical Radiology
- Vol. 57 (12) , 1078-1085
High-resolution CT Features of Severe Asthma and Bronchiolitis Obliterans
- 1 January 2002
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 40 (1) , 31-42
CT of emphysema
- 1 January 2002
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 40 (1) , 31-42
CT of emphysema